Touzani, Rajae
Rouquette, Alexandra
Schultz, Emilien
Allaire, Cécile
Carrieri, Patrizia
Mancini, Julien
Hardouin, Jean-Benoit
Funding for this research was provided by:
Santé Publique France (21DPPA040-0)
Ligue Contre le Cancer (LIGUE2019)
Article History
Received: 9 November 2023
Accepted: 24 October 2024
First Online: 7 November 2024
Declarations
:
: The French HLS<sub>19</sub> and SLAVACO studies were approved by the Ethics Evaluation Committee of the French National Health and Medical Research Institute (CEEI, IRB 00003888 and #21e770). All participants voluntarily gave their informed consent to participate in the study after being informed about the purpose of the study. The questionnaires were anonymous to ensure confidentiality and data reliability.
: Not applicable.
: The authors declare no competing interests.